Autonomix Medical, Inc.
AMIX
$1.07
$0.010.94%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 37.50% | 2.21% | 26.89% | 79.28% | 292.17% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 55.13% | 30.98% | 55.02% | 88.10% | 227.61% |
| Operating Income | -55.13% | -30.98% | -55.02% | -88.10% | -227.61% |
| Income Before Tax | -18.99% | 30.20% | 26.04% | -27.64% | -73.04% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -18.99% | 30.20% | 26.04% | -27.64% | -73.04% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -18.99% | 30.20% | 26.04% | -27.64% | -73.04% |
| EBIT | -55.13% | -30.98% | -55.02% | -88.10% | -227.61% |
| EBITDA | -56.30% | -51.56% | -115.91% | -262.98% | -- |
| EPS Basic | 58.38% | 68.06% | 60.20% | 25.84% | -0.65% |
| Normalized Basic EPS | 58.38% | 68.06% | 60.20% | 25.84% | -0.65% |
| EPS Diluted | 58.38% | 68.06% | 60.20% | 25.84% | -0.65% |
| Normalized Diluted EPS | 58.38% | 68.06% | 60.20% | 25.84% | -0.65% |
| Average Basic Shares Outstanding | 182.95% | 118.63% | 101.28% | 85.54% | 82.79% |
| Average Diluted Shares Outstanding | 182.95% | 118.63% | 101.28% | 85.54% | 82.79% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |